You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 28, 2025

Claims for Patent: 11,278,596

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 11,278,596

Title:	Insulin degludec in cardiovascular conditions
Abstract:	The present invention relates to insulin degludec for use in medicine.
Inventor(s):	Skibsted Simon, Kvist Kajsa
Assignee:	NOVO NORDISK A/S
Application Number:	US16463598
Patent Claims:

Details for Patent 11,278,596

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Sanofi-aventis U.s. Llc	LANTUS	insulin glargine	Injection	021081	April 20, 2000	⤷ Get Started Free	2037-11-28
Sanofi-aventis U.s. Llc	LANTUS	insulin glargine	Injection	021081	April 25, 2007	⤷ Get Started Free	2037-11-28
Novo Nordisk Inc.	TRESIBA	insulin degludec	Injection	203314	September 25, 2015	⤷ Get Started Free	2037-11-28
Novo Nordisk Inc.	TRESIBA	insulin degludec	Injection	203314	November 21, 2018	⤷ Get Started Free	2037-11-28
Eli Lilly And Company	BASAGLAR	insulin glargine	Injection	205692	December 16, 2015	⤷ Get Started Free	2037-11-28
Eli Lilly And Company	BASAGLAR	insulin glargine	Injection	205692	November 15, 2019	⤷ Get Started Free	2037-11-28
Sanofi-aventis U.s. Llc	TOUJEO	insulin glargine	Injection	206538	February 25, 2015	⤷ Get Started Free	2037-11-28
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 11,278,596

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2018096162	⤷ Get Started Free
United States of America	2022160840	⤷ Get Started Free
United States of America	2019374614	⤷ Get Started Free
United States of America	12233114	⤷ Get Started Free
Morocco	46897	⤷ Get Started Free
Japan	7193455	⤷ Get Started Free
Japan	2019535785	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.